Menu
| Description | MDA-MB-453 Cell Line was derived from an effusion of a 48 year old female patient with metastatic carcinoma of the breast, involving the nodes, brain and both pleural and pericardial cavities. |
| Product Name | MDA-MB-453 Cell Line |
| Cat.No | RWT-613 |
| Product category | Tumor Cell Lines |
| Size | 1*10^6 cells/vial |
| Description | MDA-MB-453 Cell Line was derived from an effusion of a 48 year old female patient with metastatic carcinoma of the breast, involving the nodes, brain and both pleural and pericardial cavities. |
| Tissue | mammary gland/breast; derived from metastatic site: pericardial effusion |
| Species | Homo sapiens, human |
| Gender | female, 48 years, Caucasian |
| Disease | metastatic carcinoma |
| Biosafety Level | BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. |
| Morphology | Epithelial-like Adherent |
| Culture Method | DMEM+ 10% FBS |
| Quality Control | MDA-MB-453 Cell Line is negative for mycoplasma, bacteria, yeast, and fungi. |
| Shipping | Cryopreserved cells are shipped with dry ice |
| Storage | Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use. |
| Warranty | MDA-MB-453 Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA. |
| Disclaimers | Our cell line product is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen. |
If use of this product results in a scientific publication, it should be cited in the publication as: MDA-MB-453 Cell Line (Runtogen RWT-613).
Inquire the MDA-MB-453 Cell Line by filling out the form below. We’ll get back to you within 24 hours with a quote.
Inquire the MDA-MB-453 Cell Line by filling out the form below. We’ll get back to you within 24 hours with a quote.
